Subpopulations of dopamine (DA)-containing neurons within the A9 and A10 regions of the midbrain contain the peptide cholecysto-kinin (CCK). Intravenously and microiontophoretically administered CCK potently excites a subpopulation of DA cells that may correspond to those cells which also contain CCK. In addition to this transient excitation, CCK exerts a more enduring modulatory effect on DA neurons with regard to their sensitivity to the inhibitory effects of intravenous apomorphine and microiontophoretic DA. Preliminary studies have shown that the excitatory and modulatory effects of CCK can also occur independently and that distinct DA pathways originating in the midbrain appear to be differentially affected by intravenous CCK. Given the relevance of midbrain DA systems to our current hypotheses regarding the neurobiology of several neurological and psychiatric disorders, a series of studies are proposed to begin to explore in more detail the interactions of CCK with identified DA neuronal subpopulations. In general, advancements in the field of CCK research have been hindered by the lack of specific and potent antagonists. Several new CCK antagonists with high affinity for central and/or peripheral CCK receptors have been developed. In the present proposal, these compounds will be employed to investigate the receptor specificity of the electrophysiological effects of CCK on identified subpopulations of DA neurons. In addition, the direct and modulatory electrophysiological effects of CCK on striatal neurons will be characterized and compared to the effects of stimulation of striatal CCK afferents. It is hoped that the information obtained from these studies will lead to a better understanding of the physiology of distinct midbrain DA neuronal pathways. This knowledge, combined with that obtained with anatomical and biochemical techniques, may aid in the formulation of testable hypotheses concerning the etiology of disorders linked to central DA neuronal dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH042136-01A1
Application #
3381207
Study Section
Neurosciences Research Review Committee (BPN)
Project Start
1988-09-01
Project End
1991-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Sinai Hospital of Detroit
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48235
Hamilton, M E; Weddige, F K; Freeman, A S (2001) Effects of forebrain microinjection of cholecystokinin on dopamine cell firing rate. Peptides 22:1063-9
Hamilton, M E; Redondo, J L; Freeman, A S (2000) Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Synapse 38:238-42
Parikh, H N; Chiodo, L A; Koss, J et al. (1995) Cholecystokinin mobilizes intracellular Ca2+ in hybrid N18TG2 X mesencephalon (MES-23.5) cells. Synapse 21:278-80
Pitts, D K; Wang, L; Kelland, M D et al. (1995) Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole. J Pharmacol Exp Ther 275:412-21
Rouillard, C; Freeman, A S (1995) Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons. Synapse 21:348-56
Hamilton, M E; Freeman, A S (1995) Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Res 688:134-42
Kelland, M D; Freeman, A S; Rubin, J et al. (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-46
Zhang, J; Chiodo, L A; Freeman, A S (1993) Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Synapse 15:276-84
Zhang, J; Chiodo, L A; Wettstein, J G et al. (1992) Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Synapse 11:267-78
Zhang, J; Chiodo, L A; Freeman, A S (1991) Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons. Peptides 12:339-43

Showing the most recent 10 out of 22 publications